• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力中的 HLA:从表面相关性到潜在机制。

HLA in myasthenia gravis: From superficial correlation to underlying mechanism.

机构信息

Department of Neurology, Huashan Hospital, Fudan University, 200040, China.

Department of Neurology, Huashan Hospital, Fudan University, 200040, China.

出版信息

Autoimmun Rev. 2019 Sep;18(9):102349. doi: 10.1016/j.autrev.2019.102349. Epub 2019 Jul 16.

DOI:10.1016/j.autrev.2019.102349
PMID:31323359
Abstract

Myasthenia gravis (MG) is a rare autoimmune disease characterized by muscle weakness and abnormal fatigability. Like many other autoimmune diseases, genetic contribution to MG has been studied where the HLA system appears to play the most vital role. Although many correlations have been revealed in these studies, the underlying mechanism for them is still in the veil. Based on current evidence, we propose two synergetic mechanisms underlying the MG predisposition via HLA. In brief, the first advocates specific MHC II-peptide patterns that influence the efficacy of antigen presentation, and the second emphasizes the role of classical MHC alleles in shaping the TCR repertoire for MG predisposition. Besides, possible explanations for unresolved or controversial MG-related epidemiological phenomenon or clinical problems are addressed as well. Then, we discuss three factors influencing the effect of HLA on MG: gender discrepancy, inflammatory microenvironment, and epigenetic regulation. Lastly, from a provisional angle, we introduce several precautious treatments for people highly predisposed to MG. Although this is a review focusing on MG, the underlying mechanisms might be applicable in other autoimmune diseases as well.

摘要

重症肌无力(MG)是一种罕见的自身免疫性疾病,其特征为肌肉无力和异常易疲劳。与许多其他自身免疫性疾病一样,MG 的遗传贡献已被研究,其中 HLA 系统似乎起着最重要的作用。尽管这些研究揭示了许多相关性,但它们的潜在机制仍不清楚。基于目前的证据,我们提出了两个通过 HLA 介导的 MG 易感性的协同机制。简而言之,第一个主张特定的 MHC II-肽模式,这些模式影响抗原呈递的效果,第二个强调经典 MHC 等位基因在塑造 MG 易感性的 TCR 库中的作用。此外,还针对未解决或有争议的 MG 相关流行病学现象或临床问题提出了可能的解释。然后,我们讨论了影响 HLA 对 MG 影响的三个因素:性别差异、炎症微环境和表观遗传调控。最后,从暂定的角度出发,我们介绍了几种针对 MG 高易感性人群的预防措施。虽然这是一篇聚焦 MG 的综述,但潜在机制也可能适用于其他自身免疫性疾病。

相似文献

1
HLA in myasthenia gravis: From superficial correlation to underlying mechanism.重症肌无力中的 HLA:从表面相关性到潜在机制。
Autoimmun Rev. 2019 Sep;18(9):102349. doi: 10.1016/j.autrev.2019.102349. Epub 2019 Jul 16.
2
Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.伊朗南部患者中HLA-DQA1*0101/2和DQB1*0502与重症肌无力的关联
Iran J Immunol. 2009 Jun;6(2):99-102.
3
Genetic basis of myasthenia gravis - a comprehensive review.重症肌无力的遗传学基础——全面综述。
J Autoimmun. 2014 Aug;52:146-53. doi: 10.1016/j.jaut.2013.12.001. Epub 2013 Dec 19.
4
Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex.自身免疫性重症肌无力的遗传学:HLA复合体的多方面贡献
J Autoimmun. 2005;25 Suppl:6-11. doi: 10.1016/j.jaut.2005.09.010. Epub 2005 Nov 2.
5
Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.重症肌无力的免疫遗传异质性及相关自身免疫性疾病:意大利北部费拉拉省的一项基于人群的调查
Acta Neurol Scand. 1994 Nov;90(5):318-23. doi: 10.1111/j.1600-0404.1994.tb02731.x.
6
HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis.沙特重症肌无力患者的HLA I类和II类多态性
Int J Immunogenet. 2009 Jun;36(3):169-72. doi: 10.1111/j.1744-313X.2009.00843.x.
7
Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.HLA 区域内的遗传异质性在三种不同的重症肌无力临床亚组中。
Clin Immunol. 2016 May;166-167:81-8. doi: 10.1016/j.clim.2016.05.003. Epub 2016 May 12.
8
Correlation of thymic pathology with HLA in myasthenia gravis.重症肌无力中胸腺病理学与人类白细胞抗原的相关性
Clin Immunol. 1999 Jun;91(3):296-301. doi: 10.1006/clim.1999.4710.
9
Human Leucocyte Antigen B50 Is Associated with Conversion to Generalized Myasthenia Gravis in Patients with Pure Ocular Onset.人类白细胞抗原B50与单纯眼肌型重症肌无力患者转为全身型重症肌无力相关。
Med Princ Pract. 2017;26(1):71-77. doi: 10.1159/000452954. Epub 2016 Oct 31.
10
Novel genetic loci associated HLA-B*08:01 positive myasthenia gravis.与 HLA-B*08:01 阳性重症肌无力相关的新遗传位点。
J Autoimmun. 2018 Mar;88:43-49. doi: 10.1016/j.jaut.2017.10.002. Epub 2017 Oct 14.

引用本文的文献

1
Telitacicept as double-targeted therapy for myasthenia gravis coexisting with connective tissue disease: three case reports.替利妥昔单抗作为重症肌无力合并结缔组织病的双靶点治疗:三例病例报告
Front Immunol. 2025 May 27;16:1552521. doi: 10.3389/fimmu.2025.1552521. eCollection 2025.
2
Rare Diseases, Spotlighting Amyotrophic Lateral Sclerosis, Huntington's Disease, and Myasthenia Gravis: Insights from Landscape Analysis of Current Research.罕见疾病,聚焦肌萎缩侧索硬化症、亨廷顿舞蹈症和重症肌无力:基于当前研究态势分析的见解
Biochemistry. 2025 Apr 15;64(8):1698-1719. doi: 10.1021/acs.biochem.4c00722. Epub 2025 Apr 1.
3
HLA Class I and II Alleles in Anti-Acetylcholine Receptor Antibodies Positive and Double-Seronegative Myasthenia Gravis Patients of Romanian Descent.
罗马尼亚裔抗乙酰胆碱受体抗体阳性和双血清阴性重症肌无力患者的HLA I类和II类等位基因
Neurol Int. 2024 Dec 10;16(6):1819-1836. doi: 10.3390/neurolint16060130.
4
[Successful treatment of rheumatoid arthritis complicated with myasthenia gravis with low-dose rituximab: A case report].[低剂量利妥昔单抗成功治疗类风湿关节炎合并重症肌无力:一例报告]
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Dec 18;56(6):1110-1114. doi: 10.19723/j.issn.1671-167X.2024.06.027.
5
Coexistence of myasthenia gravis and lichen planus: A case report and systematic review of related case reports from 1971 to 2024.重症肌无力与扁平苔藓并存:一例报告及对1971年至2024年相关病例报告的系统综述
Clin Case Rep. 2024 Jun 14;12(6):e9065. doi: 10.1002/ccr3.9065. eCollection 2024 Jun.
6
Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis.整合多组学分析确定了重症肌无力的遗传支持药物靶点和免疫细胞特异性。
J Transl Med. 2024 Mar 24;22(1):302. doi: 10.1186/s12967-024-04994-2.
7
Autoimmune thyroid disease and myasthenia gravis: a study bidirectional Mendelian randomization.自身免疫性甲状腺疾病和重症肌无力:一项双向孟德尔随机化研究。
Front Endocrinol (Lausanne). 2024 Feb 9;15:1310083. doi: 10.3389/fendo.2024.1310083. eCollection 2024.
8
An angel or a devil? Current view on the role of CD8 T cells in the pathogenesis of myasthenia gravis.天使还是恶魔?CD8 T 细胞在重症肌无力发病机制中的作用的当前观点。
J Transl Med. 2024 Feb 20;22(1):183. doi: 10.1186/s12967-024-04965-7.
9
Circulating miRNAs drive personalized medicine based on subgroup classification in myasthenia gravis patients.循环 miRNA 可根据重症肌无力患者的亚组分类推动个体化医疗。
Neurol Sci. 2023 Nov;44(11):3877-3884. doi: 10.1007/s10072-023-06933-3. Epub 2023 Jul 5.
10
Type 2 diabetes mellitus as a possible risk factor for myasthenia gravis: a case-control study.2型糖尿病作为重症肌无力的一个潜在危险因素:一项病例对照研究。
Front Neurol. 2023 Apr 17;14:1125842. doi: 10.3389/fneur.2023.1125842. eCollection 2023.